Arcturus Therapeutics Holdings Inc. (ARCT) vs Atea Pharmaceuticals, Inc. (AVIR)
A side-by-side comparison of Arcturus Therapeutics Holdings Inc. and Atea Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARCT
Arcturus Therapeutics Holdings Inc.
$13.00HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
AVIR
Atea Pharmaceuticals, Inc.
$5.07HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ARCT vs AVIR
growth of $100 · dividends reinvested · last 6yARCT -72.1% (-19.2%/yr)AVIR -83.1% (-25.6%/yr)ARCT compounded faster over this window
ARCT AVIR
ARCT vs AVIR: by the numbers
- •AVIR is the larger company ($406M vs $369M market cap).
- •Both run net losses; AVIR's is the smaller (0.00% vs -391.90% net margin).
Metrics side by side
Valuation
| Metric | ARCT | AVIR |
|---|---|---|
| P/S ratio | 15.52 | N/A |
| P/B ratio | 2.15 | 1.99 |
Profitability
| Metric | ARCT | AVIR |
|---|---|---|
| Gross margin | 95.50% | 0.00% |
| Operating margin | -111.51% | 0.00% |
| Net margin | -391.90% | 0.00% |
| ROE | -54.29% | -80.96% |
| ROIC | -54.07% | -89.93% |
Growth (annualized)
| Metric | ARCT | AVIR |
|---|---|---|
| Revenue CAGR (5Y) | 22.30% | N/A |
| Total return CAGR (5Y) | -18.73% | -34.44% |
Frequently asked
- How have ARCT and AVIR total returns compared?
- Over the past 5 years, ARCT delivered -18.73% and AVIR delivered -34.44% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arcturus Therapeutics ROEAtea Pharmaceuticals ROEArcturus Therapeutics operating marginAtea Pharmaceuticals operating marginArcturus Therapeutics revenue growthAtea Pharmaceuticals revenue growthArcturus Therapeutics free cash flowAtea Pharmaceuticals free cash flow
Arcturus Therapeutics & Atea Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.